WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: Previous page | 1,2,3,4,5,6,7,8,9,10,11

Policy and programme information

Statement on use of cotrimoxazole prophylaxis Who should get cotrimoxazole: How long should cotrimoxazole be given: Under what circumstances should cotrimoxazole be discontinued: What doses of cotrimoxazole should be used? What follow-up is required? Other operational issues Patient information Policy and programme information Monitoring and evaluation References

• National AIDS treatment, care and support policies and strategies include provision of cotrimoxazole prophylaxis
• National ARV treatment guidelines, PMTCT guidelines, and clinical care guidelines include cotrimoxazole prophylaxis for HIV exposed and HIV infected children
• Health providers at all levels are sensitized and trained to provide cotrimoxazole prophylaxis to all HIV-exposed and HIV-infected children
• Countries should supply the cotrimoxazole for children free of charge or at subsidized rates where possible

WHO, UNAIDS and UNICEF modify recommendations for cotrimoxazole prophylaxis in children: 1,2,3,4,5,6,7,8,9,10,11 | Next page